Also Read | How plant meat is coming of age in IndiaMoncef Slaoui, the chief scientific adviser to the U.S.
Operation Warp Speed program, has said the emergency clearance could be granted by U.S. regulators by early February.J&J is one of four vaccine developers running late-stage trials in South Africa.
Business Day, a Johannesburg-based newspaper, reported the planned timing of the data submission earlier. It was confirmed by Glenda Gray, president of the research council and co-chair of the local study.J&J has signed an agreement under which Aspen Pharmacare Holdings Ltd.
will manufacture 300 million doses a year in South Africa if the vaccine is approved.Click here to read the Mint ePaperMint is now on Telegram.